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In vivo transfection of NF-jB decoy oligodeoxynucleotides at-
tenuate renal ischemia/reperfusion injury in rats.
Background. Ischemic acute renal failure (ARF) is a common
and often fatal condition characterized by tubular epithelial
cell necrosis and marked monocyte infiltration. Inflammatory
mechanisms, including cell adhesion, cell infiltration, and cy-
tokine production, are involved. These processes are thought
to be directly or indirectly regulated by nuclear factor jB
(NF-jB). Targeted of NF-jB might ameliorate ischemia/
reperfusion (I/R) injury by inhibiting the production of genes
that involved in ischemic ARF. The objective of the present
study was to evaluate the effect of NF-jB decoy oligodeoxynu-
cleotides (ODN) in experimental rat ischemic ARF.
Methods. Ischemic ARF was induced by left renal artery
clamping for 60 minutes, while the right kidney was being re-
moved in female Sprague-Dawley rats. The effect of cationic
liposome-protamine-NF-jB decoy ODN was evaluated after
infusion into the kidney via the renal artery before clamp-
ing. After 24 hours of reperfusion, we then assessed morpho-
logic and functional parameters, NF-jB/DNA binding activity,
monocyte/macrophage (M/M) infiltration, and gene expres-
sion in I/R kidney.
Results. After 24 hours of reperfusion, compared with sham-
operated animals, serum creatinine and blood urea nitrogen
(BUN) levels in ischemic ARF animals were increased about
10-fold and fivefold respectively. (255.67 ± 34.48 lmol/L vs.
25.33 ± 2.23 lmol/L and 43.47 ± 5.50 mmol/L vs. 8.45 ±
0.43 mmol/L, P < 0.001), NF-jB/DNA binding activity was
markedly elevated [median value was 1.75 vs. 0.15 relative
density unit (RDU), P < 0.005]. NF-jB decoy ODN treat-
ment reduced the elevation of serum creatinine level by 70%
(79.17 ± 8.64 lmol/L vs. 255.67 ± 34.48 lmol/L, P < 0.01),
BUN level by 40% (28.33 ± 4.86 mmol/L vs. 43.47 ± 5.50
mmol/L, P = NS), and almost abolished the NF-jB activation
compared with levels observed in sham-operated rats (median
value was 0.25 vs. 1.9 RDU, P < 0.005). Furthermore, NF-jB
decoy ODN pretreatment prevented the occurrence of tubular
necrosis and reduced the renal tubular damage scores markedly
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(1.85 ± 0.06 vs. 3.63 ± 0.06 scores, P < 0.01). In addition,
M/M infiltration was obviously suppressed (9.77 ± 1.19 cells/
hpf vs. 29.22 ± 1.94 cells/hpf, P < 0.01), Moreover, results
of reverse transcription-polymerase chain reaction (RT-PCR)
and immunohistochemistry showed the up-regulation of mono-
cyte chemoattractant protein-1 (MCP-1) and intercellular ad-
hesion molecule-1 (ICAM-1) was greatly decreased, inducible
nitric oxide synthase (iNOS) and endothelin-1 (ET-1) expres-
sion were also reduced, approaching levels observed in sham-
operated animals. The data suggest that NF-jB decoy ODN
treatment protects renal tissue from the effects of I/R injury
and thus reduces the severity of ARF.
Conclusion. These experiments demonstrated that NF-jB
plays a critical role in renal I/R injury by reducing a series of
inflammatory genes. NF-jB decoy ODN treatment reduces the
renal dysfunction and damage associated with ischemic ARF.
Therefore, in vivo transfection of NF-jB decoy ODN provides
a new therapeutic strategy for ischemic ARF.
Acute renal failure (ARF) is a common problem in hos-
pitalized patients and results in significant high mortal-
ity. Renal ischemia/reperfusion (I/R) injury remains the
leading cause of ARF after major operation or trauma
[1, 2]. Despite tremendous experimental ameliorative
strategies having been tested during the past decades,
there is yet no definitive evidence supporting specific
prophylactic therapies in any setting. The mortality is
between 50% and 70% in many studies [1–3]. The re-
sponse to I/R insults is characterized by tubular epithelial
cell necrosis and marked leukocytes, including mono-
cytes/macrophages (M/M) infiltration [4, 5]. The infil-
tration of M/M is facilitated by chemotactic factors.
Monocyte chemoattractant protein-1 (MCP-1) is a potent
chemokine that stimulates M/M recruit into the renal
interstitium in acute and chronic renal diseases, and its
elevated expression might be responsible for increased
M/M influx and activation in the ischemic injured kid-
ney [6–8]. These infiltrated M/M can, in turn, potentiate
the inflammatory response by releasing cytokines, vaso-
constrictors, enzymes, and adhesion molecules such as
endothelin-1 (ET-1) [9], inducible nitric oxide synthase
(iNOS) [10, 11], and intercellular adhesion molecule-1
834
Cao et al: In vivo transfection of NF-jB decoy ODNs and renal I/R injury in rats 835
(ICAM-1) [12], which have been reported to be involved
in the pathogenesis of renal injury after I/R. The regula-
tion of these molecules is dependent on the transcription
factor nuclear factor-kappa B (NF-jB) [13, 14]. NF-jB
exists in an inactive form in the cytoplasm, binding to the
inhibitory protein IjB. A variety of physiologic and non-
physiologic stimuli, including cytokines, mitogens, and
oxidants, leads to proteolytic degradation of IjB, thus
allowing NF-jB translocation into the nucleus where it
binds to the jB binding site in the promoter regions of
target genes, activating the transcription of these corre-
sponding genes. Increasing data suggest a pivotal role
of NF-jB in a variety of pathophysiologic conditions,
including I/R renal injury [14]. Therefore, NF-jB is an
important therapeutic target [15, 16].
Previously, the decoy strategy has been developed and
considered as a new class of antigene approach in vitro
and in vivo [17, 18]. Transfection of doubled-stranded
oligodeoxynucleotides (ODNs) as decoy sequences cor-
responding to the cis sequence results in attenuation of
the authentic of cis transinteraction, leading to the re-
moval of the tranfactors from the endogenous cis ele-
ment, with subsequent modulation of gene expression
[17, 19, 20]. Since NF-jB plays such a pivotal role in
the pathophysiology of many disorders, it is conceivable
that exogenous modulation of NF-jB activation by NF-
jB decoy ODN maybe help to devise new therapeutic
approaches [14, 20, 21]. In fact, the NF-jB decoy strat-
egy had been shown a clear therapeutic potential in many
disease, such as myocardial infarction [22], glomeru-
lonephritis [20], cancer metastasis [23], and renal allograft
[24, 25].
The aim of this study was to transfect NF-jB decoy
ODN delivered by cationic lipid-protamine via perfusion
of renal artery to investigate whether NF-jB decoy treat-
ment affect NF-jB activities in the kidney, prevented the
infiltration of M/M, decreased the expression of MCP-1,
ICAM-1, iNOS, and ET-1 thus attenuated I/R injury in
ischemic ARF rats.
METHODS
ODNs and liposomes
ODNs were synthesized by Sangon Biological Engi-
neering Technology and Service Co. (Shanghai, China).
Synthetic ODNs were dissolved in sterile Tris ethylene-
diaminetetraacetic acid (EDTA) buffer (10 mmol/L Tris,
1 mmol/L EDTA). The phosphorothioate single-stranded
ODN were annealed for 2 hours while the temperature
decreased from 80◦C to 25◦C.
Sequences of NF-jB decoy ODN containing both the
specific p50 (GGGAC) and p65 (TTCC) jB binding sites
were [26]: 5′-AGT TGA GGG GAC TTT CCC AGG C-3′
and 3′-TCA ACT CCC CTG AAA GGG TCC G -5′. Se-
quences of scrambled ODN, nonsensed sequences were
[25]: 5′-TTG CCG TAC CTG ACT TAG CC-3′ and 3′-
AAC GGC ATG GAC TGA ATC GG-5′. Sense-strand
ODN was fluorescein isothiocyanate (FITC)-labeled at
the 3′ end for preparing for the initial studies.
Cationic liposomes consisting of a mixture of 1:1 1-
2-Dioleoyl-3-trimethylammonium-propane (DOTAP)/
cholesterol were purchased from Dr. Templeton (Bay-
lor College of Medicine, Houston, TX, USA). Cationic
liposome-protamine-ODN/DNA (LPD) complexes were
prepared just before use in a 4:1 LPD charge ratio [27,
28].
Animals and surgical procedures of renal ischemic model
Experiments were performed with female Sprague-
Dawley rats (250 to 280 g) purchased from Animal
Center, Shanghai Medical College, Fudan University
(Shanghai, China). The rats received a standard diet,
with free access to tap water. All procedures were per-
formed according to the guidelines of the Fudan Univer-
sity Committee For the Use of Live Animals in Teaching
and were approved by local authorities. Rats were indi-
vidually housed at 21◦C to 23◦C, 12-hour light/dark cycle.
Rats were anesthetized with sodium pentobarbital
(50 mg/kg) intraperitoneally. Through a midline flank in-
cisions, right nephrectomy was performed, the left renal
artery was carefully isolated and perfused with 200 lL
liposome-protamine-NF-jB decoy ODN, or liposome-
protamine-scrambled ODN or 0.9% saline into the kid-
ney by a 32 gauge syringe needle (Terumo, Tokyo, Japan)
within 1 minute. Correspondently, these animals were
divided into decoy, scrambled, and ARF group, respec-
tively. The renal artery was clamped with nontraumatic
microvascular clamp for 60 minutes. After the clamp
was removed, reperfusion was confirmed visually by the
blood flow returning to the kidney. The animals received
warm saline instilled into peritoneal cavity and was main-
tained core body temperature at 38◦C ± 1◦C using a
homeothermic table during surgery. We also included a
sham-operated group of rats that underwent a similar
surgical procedure but without isolating and clamping of
renal artery.
After 24 hours, rats were anesthetized again and per-
fused, via the aorta, with 100 mL cold phosphate-buffered
saline (PBS). Their kidneys were harvested and divided
into two parts. For paraffin histologic assessments and
immunohistochemical analyses, one part of the kidneys
were fixed in 10% buffered formaldehyde for 48 hours.
For electrophoretic mobility shift assay (EMSA) and
Western blotting, the other parts of the kidneys were
snap-frozen in liquid nitrogen. Blood samples were ob-
tained at the time of euthanasia. Serum creatinine and
blood urea nitrogen (BUN) were measured using an au-
tomated method.
A series of preliminary studies was performed in
normal rats, whose left kidneys were perfused with
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FITC-labeled ODN alone or FITC-labeled ODN com-
plexed with liposome-protamine. Rats were sacrificed at
three time points: 2 hours, 12 hours, or 24 hours. The
tissues were examined by fluorescence microscope to de-
termine transfection efficacy.
EXTRACTION OF NUCLEAR PROTEIN
Nuclear proteins from kidney tissues were prepared
as described previously with some modifications [29].
Kidney tissues, 100 lg, were homogenized using a Poly-
tron homogenizer (Kinematica, Switzerland) in 200 lL
ice-cold homogenization buffer, composed of 10 mmol/L
Hepes, pH 7.9, 2 mmol/L MgCl2, and 0.1 mmol/L EDTA,
with a cocktail of protease inhibitors [0.5 mmol/L dithio-
threitol, 0.1 mmol/L pepstatin A, 1 lmol/L phenylmethyl-
sulfonyl fluoride (PMSF), 0.05 lg/mL leupeptin, and 0.01
mmol/L aprotonin]. In addition, 65 lL NP-40 was added.
The mixture was votexed 10 times for 1 minute each, and
was centrifuged at 12,000g for 30 minutes at 4◦C, the pel-
let was lysed in 60 lL ice-cold homogenization buffer
containing 50 mmol/L Hepes, 10% glycerol, 300 mmol/L
NaCl, 50 mmol/L KCl, and a cocktail of protease in-
hibitors. It was then votexed vigorously five times for
2 minutes each, the mixture was centrifuged at 12, 000g
for 30 minutes at 4◦C. The supernatant was nuclear pro-
tein, and it was diluted to a standard concentration of 3 lg/
lL and stored in aliquots at −70◦C. The protein concen-
tration was determined by the Bradford method (Bio-
Rad protein assay) (Bio-Rad Laboratories, Hercules, CA,
USA).
EMSA
Preparation for EMSA was performed with a com-
mercial kit following the instructions of the manufac-
ture (Promega). Briefly, NF-jB binding site ODN, which
sequence is identical to NF-jB decoy ODN, was radi-
olabeled with c-32P with the use of T4 polynucleotide
kinase with standard methods. Nuclear extracts (10 lg)
were incubated in binding reaction medium with 0.5 ng
of 32P-end-labeled oligonucleotide, containing the NF-jB
binding site ODN for 30 minutes at room temperature.
The DNA-protein complexes were analyzed on 5% poly-
acrylamide gels, and autoradiographed. In competition
assays, 50 ng of unlabeled NF-jB decoy ODN or scram-
bled ODN were used [30].
Morphologic evaluation and scoring
Kidney sections from paraffin-embedded tissues were
prepared at 4 lm thickness and stained with hematoxylin
and eosin using standard procedures for histologic eval-
uation. Sections were reviewed in a blinded manner by a
renal pathologist and scored with a previously described
semiquantitative scale designed to evaluate the degree
of tubulointerstitial injury according to tubular necrosis,
tubular dilatation and/or atrophy, inflammatory cell in-
filtration, or cellar edema [31, 32]. Injury was graded on
a scale of 0 to 4. Higher scores represented more severe
damage (maximum score, 4): 0, normal kidney; 1, min-
imal damage (<5% involvement of the cortex or outer
medulla); 2, mild damage (5% to 25% involvement of
the cortex or outer medulla); 3, moderate damage (25%
to 75% involvement of the cortex or outer medulla); and
4, severe damage (>75% involvement of the cortex or
outer medulla).
Immunohistochemical analysis for M/MΦ, MCP-1,
and iNOS
The immunostaining was processed in 4lm paraf-
finized sections. After deparaffinization, endogenous per-
oxidase activity was blocked with 0.3% (vol/vol) hy-
drogen peroxide (H2O2) in water for 10 minutes at
room temperature. Sections were subjected to microwave
irradiation in citrate buffer to enhance antigen re-
trieval. Nonspecific adsorption was minimized by incu-
bating the section in 2% (vol/vol) normal goat serum
in PBS for 20 minutes. Sections were then incubated
with a 1/1000 against ED-1 (mouse antirat antibody)
(Chemicon International, Inc., Temecula, CA, USA),
or MCP-1 (rabbit antirat) (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA), or iNOS (rabbit anti-
rat) (Santa Cruz Biotechnology, Inc.), or with control
solutions in a humidified chamber overnight at room
temperature. Controls included buffer alone or non-
specific purified mouse or rabbit IgG. Specific labeling
was detected with a biotin-conjugated rabbit antimouse,
or goat antirabbit IgG and avidin-biotin peroxidase
complex (Vector Laboratories, Burlingame, CA, USA).
To verify the binding specificity for MCP-1 or iNOS (neg-
ative controls), some sections also were incubated with
only the secondary antibody (no primary antibody). The
color reaction was developed with 3,3-diaminobenzidine,
and sections were counterstained with methyl green or
hematoxylin. An independent renal pathologist, with no
prior knowledge of experimental protocols, examined the
immunostained sections. ED-1–positive cells were quan-
titatively measured by counting 20 randomly selected
high power fields (×400) in cortex and outer medulla
area. The positive stained area of MCP-1 or iNOS pro-
teins was quantitatively measured using a computer-
aided image system (IMS) (Shenteng IT Co., Shanghai,
China) and digitalized images that were transformed
from analogue images taken by a video camera (Pana-
sonic, MV-CP410, Japan). Each field was 72 800 lm2. A
total of 10 randomly selected fields in cortex and outer
medulla area per section were counted for each animal in
all groups. The positive-stained area of MCP-1 or iNOS
proteins was expressed as lm2.
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Analysis of MCP-1, ICAM-1, iNOS, and ET-1 mRNA
Kidney tissues samples were homogenized in Tri-
zol reagent (Life Technologies, Carlsbad, CA, USA), a
monophasic solution of phenol and guanidine isothio-
cyanate, for the isolation of total RNA and proteins. Ex-
traction of total RNA was performed according to the
manufacturer’s directions with Trizol, and the concentra-
tion was measured by spectrophotometry at 260 nm. The
expression of mRNAs in the kidney was examined by
semiquantitative reverse transcription-polymerase chain
reaction (RT-PCR) analysis. Primers for MCP-1, ICAM-
1, iNOS, ET-1, and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) are listed:
Sense/antisense Fragment
MCP-1 5′-CTC TTC CTC CAC CAC TAT GC-3′ 457 bp
5′-GAA GTG ACC AGT ATG ACA GAG-3′
ICAM-1 5′-AAG GTG TGA TAT CCG GTA GA -3′ 588 bp
5′-CCT TCT AAG TGG TTG GAA CA-3′
iNOS 5′-ACACAGGTAGACCCTAAGAGTCACAAG-3′ 446 bp
5′-CTGTTGGACCACTGAATCCTGCCGATG-3′
ET-1 [33] 5′-TGG CTT TCC AAG GAG CTC C-3′ 339 bp
5′-GCT TGG CAG AAA TTC CAG C-3′
GAPDH 5′-AATGCATCCTGCACCACCAA-3′ 515 bp
[34] 5′-GTAGCCATATTCATTGTCATA-3′
In brief, the total RNA was used in the reverse tran-
scription reaction. The reaction mixture (20 mL) for
PCR contained 1.25 U Taq DNA polymerase. Tubes
were placed on a Thermal Cycler (Biometra, T-Gradient
Themoblock, Goettingen, Germany), which was pro-
grammed as follows: incubation 95◦C for 9 minutes, then
following sequential steps: (1) MCP-1 95◦C for 30 sec-
onds, 56◦C for 30 seconds, 72◦C for 1 minute, 33 cycles;
(2) ICAM-1 95◦C for 30 seconds, 56◦C for 30 seconds,
72◦C for 1 minute, 36 cycles; (3) iNOS 95◦C for 30 sec-
onds, 60◦C for 30 seconds, 72◦C for 1 minute, 45 cycles;
(4) ET-1 95◦C for 30 seconds, 56◦C for 30 seconds, 72◦C
for 1 minute, 36 cycles; and (5) GAPDH 95◦C for 30 sec-
onds, 56◦C for 30 seconds, 72◦C for 1 minute, 26 cycles.
Finally, incubation was done at 72◦C for 7 minutes. The
optimum number of amplification cycles used for quan-
titative RT-PCR was chosen based on pilot experiments
that established the exponential range of each reaction.
In all experiments, the presence of possible contaminants
was checked by control reactions in which amplification
was carried out in the absence of reverse transcriptase.
PCR-amplified products were saved and kept at −20◦C
until analysis. PCR products of MCP-1and GAPDH,
ICAM-1 and GAPDH, iNOS and GAPDH, and ET-1
and GAPDH were then separated by 1.2% agarose gel
electrophoresis in the same gel, respectively, and visual-
ized using the Visionary Gel Documentation System (Bio
Cell Consulting, Reinach, Switzerland). Optical density
of mRNA for PCR products was quantified using scan-
ning densitometry (Molecular Dynamics, Sunnyvale, CA,
USA).
Statistical analysis
Data are expressed as mean ± standard error mean
(SEM) or median (M) as appropriate in this study. Statis-
tical analyses were performed using analysis of variance
(ANOVA) test, followed by the Student-Neumann-Keuls
test. To compare NF-jB activities, Wilcoxon rank-sum
test was used. The differences were evaluated with SPSS
10.0 software (SPSS, Chicago, IL, USA). Significant dif-
ferences were accepted at P < 0.05.
RESULTS
Distribution of NF-jB decoy ODN delivered
by cationic lipid-protamine
In preliminary experiments, the left kidneys were per-
fused with FITC-labeled ODN alone or FITC-labeled
ODN complexed with liposome-protamine. Rats were
sacrificed at three time points: 2 hours, 12 hours, or
24 hours. The tissues were examined by fluorescence mi-
croscopy to determine transfection efficiency (Fig. 1). As
early as 2 hours after infusion, FITC-labeled ODNs were
mainly present in glomeruli (Fig. 1B), whereas, 12 hours
later, in proximal tubules (Fig. 1C). After 24 hours, there
was no detection of fluorescence in either glomeruli or
tubules (data not shown).
NF-jB decoy ODN inhibited NF-jB activities
in ischemic ARF
To investigate whether NF-jB was activated in the
kidney during I/R, NF-jB/DNA binding activities were
assessed in kidney nuclear proteins from each group
rats using EMSA. The autoradiographs of the polyacry-
lamide gels are shown in Figure 2. The sham operation
resulted in slight NF-jB activation. In relation to sham-
operated rats, ischemic ARF rats showed a significant el-
evation in NF-jB activities in the kidney after I/R injury.
NF-jB decoy ODN, but not the scrambled ODN, signifi-
cantly blocked the I/R-stimulated NF-jB activation and
decreased to sham-group values. The reaction was proved
to be specific since an excess of unlabeled NF-jB decoy
ODN decreased the signal of the retarded bands.
NF-jB decoy ODN attenuated the I/R renal injury
As demonstrated in Table 1, animals that underwent
60 minutes of renal ischemia and 24 hours reperfusion
exhibited a significant degree of renal dysfunction, as re-
flected in a 10-fold elevation in creatinine and fivefold
elevation in BUN concentrations, compared to the sham-
operated rats. Compared with ischemic ARF group ani-
mals, pretreatment of rats with NF-jB decoy, the serum
creatinine level decreased by 70%. Administration of the
scrambled ODN did not result in any significant alter-
ations of serum creatinine and BUN levels.
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Fig. 1. Distribution of fluorescein isothiocyanate (FITC)-labeled
oligodeoxynucleotides (ODN) in rat kidney. In vivo transfection of
FITC-labeled ODN complexed with cationic liposome-protamine via
infusion into rat left renal artery, fresh kidney sections were exam-
ined under fluorescence microscopy after staining in erichrome black
T solution. Sham-operated animal kidney sections stained red (A), red
nonspecific background fluorescence was readily distinguishable from
the yellow specific FITC-labeled ODN fluorescence in (B) and (C). The
distribution of FITC-labeled ODN fluorescence in kidney was differ-
ent in different time point. Two hours after transfection, fluorescence
was mainly localized in glomeruli (B); 12 hours later, fluorescence was
widely presented in proximal tubules (C) (magnification, ×400). G is
glomerulus. Arrows point to proximal tubules.
To substantiate the effects of NF-jB decoy treatment
on renal function after ischemia, we next studied the ef-
fects of NF-jB decoy on ischemia-induced tissue dam-
age. Representative examples of these experiments are
presented in Figure 3. On comparison with the normal
renal histology observed in kidneys taken from sham-
operated rats (Fig. 3A), animals that underwent renal I/R
demonstrated the recognized features of tubular damage
in cortex and outer medullary stripe (Fig. 3B). These fea-
tures included tubular dilation, brush border loss, detach-
ment of epithelial cells from the basement membrane,
which left naked basement membranes and caused tubu-
lar obstruction, interstitial edema, and inflammatory cells
infiltration. Kidneys obtained from rats pretreated with
NF-jB decoy demonstrated reduced histologic features
of renal injury on comparison with kidneys obtained from
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Fig. 2. Representative specificity and effect of nuclear factor-jB
(NF-jB) decoy oligodeoxynucleotides (ODN) on NF-jB/DNA binding
activity in rat kidneys. (A) Upon ischemia/reperfusion (I/R), nuclear
extracts were isolated from each group rat kidneys. Electrophoretic
mobility shift assay (EMSA) was performed to determine NF-jB/DNA
binding activity. Lanes 1 to 4 show the specificity of NF-jB decoy ODN
(lane 1, labeled probe with no extract; lane 2, labeled probe with extract
from ischemic acute renal failure (ARF) renal tissues; lane 3, labeled
probe with extract the same as that in lane 2 plus 100-fold excess of
unlabeled NF-jB decoy ODN; and lane 4, labeled probe with extract
the same as that in lane 2 plus 100-fold excess of unlabeled scrambled
ODN). Lanes 5 to 8 showed NF-jB activities in each group rat kidneys
(lane 5, sham-operated animals; lane 6, ischemic ARF animals; lane
7, NF-jB decoy ODN-treated animals; and lane 8, scrambled ODN-
treated animals). (B) Densitometric analysis of NF-jB/DNA binding
activities. Densitometry was performed on autographs. Values were me-
dian (M) relative density unit (RDU) of each group (N = 6 per group).
∗∗P < 0.01 versus sham-operated group; #P < 0.05 versus ischemic ARF
group.
ischemic ARF rats. Markedly reduced tubule necrosis, in-
terstitial edema, and inflammatory cells infiltration were
observed in kidneys obtained from NF-jB decoy pre-
treated animals (Fig. 3C). Administration of scrambled
ODN did not have a significant effect on the damage
(Fig. 3D).
As shown in Table 1, compared with the total sever-
ity score measured from kidneys obtained from sham-
operated animals, renal I/R produced a significant
increase in total severity score. Administration of NF-jB
decoy, the total severity score was significantly reduced.
Administration of scrambled ODN did not have a signifi-
cant effect on total severity score when compared to that
obtained from control animals.
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Table 1. Concentrations of blood urea nitrogen (BUN), serum creatinine, histopathologic scores, and number of monocytes/macrophags (M/M)
(cells/hpf)) in the four groups of rat kidneys
Serum creatinine Histopathologic Number of M/M
Group BUN mmol/L lmol/L scores cells/hpf
Sham 8.45 ± 0.43 25.33 ± 2.23 0.00 ± 0.00 2.46 ± 0.74
Ischemic ARF 43.47 ± 5.50a 255.67 ± 34.48a 3.63 ± 0.06a 29.22 ± 1.94a
NF-jB 28.33 ± 4.86 79.17 ± 8.64b 1.85 ± 0.06b 9.77 ± 1.19b
Scrambled 47.01 ± 6.98 262.67 ± 32.13 3.55 ± 0.11 28.75 ± 1.88
Abbreviations are: ARF, acute renal failure; NF-jB, nuclear factor-kappaB.
Values are expressed as mean ± SEM (N = 6 per group).
aP < 0.01 versus sham-operated group; bP < 0.01 versus ischemic ARF group.
Fig. 3. Effect of nuclear factor-jB (NF-jB)
decoy oligodeoxynucleotides (ODN) on re-
nal histologic damage in rat kidney. Rat kid-
neys were subjected to 60 minutes of ischemia
followed by 24 hours of reperfusion. Kidney
tissues were fixed in 10% neutral-buffered
formalin for 48 hours and then embedded
in paraffin. The renal sections were hema-
toxylin and eosin-stained and examined us-
ing light microscopy at a magnification ×400.
(A) Sham-operated rats had minimal patho-
logical changes in the kidneys. (B) After
ischemia/reperfusion (I/R), the kidneys ap-
peared more severe lesions in tubulointer-
stitium, with loss of the brush border, de-
tachment of epithelial cells from the base-
ment membrane, tubular obstruction, and cel-
lar edema. (C) Pretreatment with NF-jB de-
coy ODN caused significant reduction in the
severity of acute tubular necrosis. (D) Pre-
treatment with scrambled ODN had no effects
on the severity of renal histologic damage.
NF-jB decoy ODN inhibited M/MΦ infiltration,
MCP-1, and ICAM-1 expression
The infiltration of M/M was assessed by immunos-
taining analysis. Compared to the sham-operated group,
the number of interstitial cells demonstrating ED-1
staining for M/M was significantly increased after I/R
(Table 1) (Fig. 4). These cells were massively distributed
in the interstitium, especially in the outer medulla. Pre-
treatment with NF-jB decoy substantially blocked the
infiltration of M/M. We observed an almost 66% de-
crease in M/M infiltration with NF-jB decoy treatment
(Table 1).
The expression of MCP-1 and ICAM-1 mRNA was ex-
amined by RT-PCR. As shown in Figure 5 and Table 2,
MCP-1 and ICAM-1 mRNA level elevated significantly
after 60 minutes of ischemia and 24 hours of reperfusion
in ischemic ARF rats, compared to sham-operated rats. It
was significantly decreased in NF-jB decoy ODN-treated
animals. To further investigate the distribution of MCP-1
protein in the kidney, immunohistochemical staining was
determined. There was no staining for MCP-1 in kid-
neys obtained from sham-operated rats but a stronger
staining in proximal tubules in kidneys obtained from
rats subjected to I/R. Kidneys obtained from rats pre-
treated with NF-jB decoy ODN demonstrated markedly
reduced staining for MCP-1 (Fig. 6).
NF-jB decoy ODNs reduced the expression
of iNOS and ET-1
As shown in Figure 5 and Table 2, using RT-PCR anal-
ysis, we observed that I/R injury caused significant el-
evations of iNOS and ET-1 mRNA expression. When
compared to sham-operated rats (Fig. 7A), immunohisto-
chemical analysis revealed that positive staining for iNOS
massively distributed in cortical tubular epithelia and per-
itubular interstitium in renal I/R (Fig. 7B). NF-jB decoy
ODN treatment blocked the up-regulation levels of iNOS
and ET-1 mRNA expression (Fig. 5) (Table 2), and re-
duced the location of iNOS peptides (Fig. 7C). Scram-
bled ODN had no effects on their expression (Fig. 5)
(Table 2) (Fig. 7D).
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Fig. 4. Representative of infiltration of ED-
1–positive monocyte/macrophage (M/MΦ) in
rat kidneys. Rat kidneys were subjected to
60 minutes of ischemia followed by 24 hours
of reperfusion. Kidney tissues were fixed in
10% neutral-buffered formalin for 48 hours
and then embedded in paraffin. Immunohis-
tochemical staining for M/M was performed
with anti-ED-1 antibody. After counterstain-
ing with methyl green, ED-1–positive cells
were identified under light microscope at
a magnification of ×400. (A) The sham-
operated rat resulted in solitary infiltrating
cells. (B) Ischemia/reperfusion (I/R) caused
severe infiltration of ED-1–positive cells into
renal interstitium. (C) Pretreatment with
nuclear factor-jB (NF-jB) decoy oligodeoxy-
nucleotides (ODN) reduced the influx of
ED-1–positive cells. (D) Pretreatment with
scrambled ODN had no effects on the infil-
tration of ED-1–positive cells. Arrows point
to ED-1–positive cells.
M 1 2 3 4 5 6 7 8
MCP−1
(457 bp)
ICAM−1
(588 bp)
iNOS
(466 bp)
ET−1
(339 bp)
Fig. 5. Effect of nuclear factor-jB (NF-jB) decoy oligodeoxynu-
cleotides (ODN) on the expression of monocyte chemoattractant
protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1), in-
ducible nitric oxide synthase (iNOS), and endothelin-1 (ET-1) mRNA
in the kidney. Total RNA was prepared from each group rat kid-
neys. Each molecule mRNA was measured by semiquantitative reverse
transcription-polymerase chain reaction (RT-PCR) analysis. Lane 1,
sham-operated animals; lane 2, ischemic ARF animals; lane 3, NF-jB
decoy ODN-treated animals; lane 4: scrambled ODN-treated animals.
Glyeraldehyde-3-phosphate dehydrogenase (GAPDH) (lanes 5 to 8)
was included as a control for mRNA loading. M is marker; marker
ladder is 100 bp.
DISCUSSION
Transcription factor NF-jB is critical for the activa-
tion of genes involved in many renal disease models [14].
The present study demonstrated that (1) LPD method
showed a high efficiency in kidney transfection; (2) I/R-
activated NF-jB stimulate the expression of MCP-1 and
ICAM-1, resulting in the infiltration of M/M into renal
interstitium, and enhanced the expression of iNOS and
ET-1 in rat ischemic ARF model; and (3) inhibition of NF-
jB activation using NF-jB decoy strategy documented a
strong renoprotective effect, which is consistent with the
marked reduction in histologic damage, M/M infiltra-
tion, and cytokines expression in I/R injury.
The transcription factor decoy strategy using a
doubled-stranded ODN corresponding to cis sequence
has been shown to be a new effective class of antigene
approach in vitro and in vivo and it enables us to treat a
broad range of diseases by modulating endogenous tran-
scriptional regulation [18, 19, 22, 23, 25, 35]. However,
success of decoy ODN transferring into target tissue cells
depends upon the development of delivery vehicles or
vectors [36, 37]. It has been reported that the adenovi-
ral method is efficient for tubular transfection in vivo.
But viral vectors, although highly efficient, suffer from
a number of problems such as immunogenicity, toxicity,
and potential recombinations or complementation [38,
39]. Retroviral vectors do not constitute suitable deliv-
ery systems for a normal kidney, most likely because
kidney cells have a very low mitotic activity [39]. As a
result of these limitations, many efforts have been de-
voted to the development of nonviral vectors such as
cationic liposomes. Cationic liposomes are particularly
attractive in alternative to viral vector due to their fa-
vorable characteristics such as biocompatibility, minimal
toxicity, lack of specific immune, relative ease of large-
scale production, and simplicity of use [39–41]. They are,
however, hampered by reports of minimal efficiency in
vivo [42]. Previous studies have shown that hemagglu-
tinating virus of Japan (HVJ)-liposome method, which
takes advantages of fusigenic protein (HN and F glyco-
proteins) of HVJ viral envelope that mediate fusion with
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Table 2. Semiquantitative polymerase chain reaction (PCR) analysis of monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion
molecule-1 (ICAM-1), inducible nitric oxide synthase (iNOS), and endothelin-1 (ET-1) mRNA in the four groups of rat kidneys
Sham Ischemic ARF NF-jB decoy Scrambled
MCP-1 0.150 ± 0.022 1.212 ± 0.097a 0.270 ± 0.028b 1.215 ± 0.055
ICAM-1 0.233 ± 0.022 1.780 ± 0.126a 0.245 ± 0.025b 2.017 ± 0.181
iNOS 0.102 ± 0.012 1.450 ± 0.058a 0.255 ± 0.020b 1.312 ± 0.113
ET-1 0.140 ± 0.015 0.972 ± 0.016a 0.367 ± 0.019b 1.033 ± 0.042
Abbreviations are: ARF, acute renal failure; NF-jB, nuclear factor-kappaB.
Values are expressed as mean ± SEM of relative amount of each mRNA normalized to amount of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA
(N = 6 per group).
aP < 0.001 versus sham-operated group; bP < 0.001 versus ischemic ARF group.
Fig. 6. Immunohistochemical localization of
monocyte chemoattractant protein-1 (MCP-
1) in kidneys. Rat kidneys were subjected to
60 minutes of ischemia followed by 24 hours
of reperfusion. Kidney tissues were fixed in
10% neutral-buffered formalin for 48 hours
and then embedded in paraffin. Immunohis-
tochemical staining for MCP-1 was performed
with anti-MCP-1 antibody. After counter-
staining with hematoxylin, MCP-1 protein
was identified under light microscope at a
magnification of ×400. (A) Sham-operated
rat had no staining for MCP-1. (B) Ischemia/
reperfusion (I/R) caused stronger staining for
MCP-1 in proximal tubules in kidneys. (C)
Pretreatment with nuclear factor-jB (NF-jB)
decoy oligodeoxynucleotides (ODN) reduced
the staining for MCP-1. (D) Pretreatment
with scrambled ODN had no effects on the
staining for MCP-1. Arrows point to MCP-
1 protein. (E) Semiquantitative analysis of
immunohistochemical staining of MCP-1 ex-
pression. Data were expressed as mean ±
SEM lm2 positive area/field from six animals
per group. ∗∗P < 0.01 versus shamed-operated
group; ##P < 0.001 versus ischemic acute renal
failure (ARF) group.Sham ARF NF-κ B Scrambled
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cell membrane at neutral pH, effectively transferred of
many genes, ODNs in vivo [43]. However, not only the
processes to acquire the purified HVJ are tedious and
complex but also the application of the method is limited
in a few laboratories. In this study, we demonstrated the
feasibility of liposome protamine mediated DNA/ODN
(LPD) transfect into kidney via the renal artery. LPD is
a novel lipid vector that was recently developed. These
nanoparticles are about 10 nm in diameter; contain a
core of protamine-condensed DNA coated with a lipid
shell, very like enveloped virus. Compared with cationic
lipid/DNA complexes, LPD is much more stable and also
more efficient in transfecting cells in vitro [37, 44]. Our
previous study shown that tranfection efficacy of NF-jB
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Fig. 7. Immunohistochemical localization
of inducible nitric oxide synthase (iNOS)
in kidneys. Rat kidneys were subjected
to 60 minutes of ischemia followed by 24
hours of reperfusion. Kidney tissues were
fixed in 10% neutral-buffered formalin for
48 hours and then embedded in paraffin.
Immunohistochemical staining for iNOS was
performed with anti-iNOS antibody. After
counterstaining with hematoxylin, iNOS pro-
tein was identified under light microscope at
a magnification of ×400. (A) Sham-operated
rat had faint staining for iNOS. (B) Ischemia/
reperfusion (I/R) caused stronger staining
for iNOS in proximal tubules in kidneys.
(C) Nuclear factor-jB (NF-jB) decoy
oligodeoxynucleotides (ODN) treatment
inhibited up0regulated iNOS to low levels.
(D) Scrambled ODN had no effects on the
staining for iNOS. Arrows point to iNOS
protein. (E) Semiquantitative analysis of
immunohistochemical staining of iNOS
expression. Data were expressed as mean ±
SEM lm2 positive area/field from six animals
per group. ∗∗P < 0.01 versus shamed-operated
group. ##P < 0.001 versus ischemic acute
renal failure (ARF) group.Sham ARF ScrambledNF-κ B
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decoy ODN using LPD method reached 93.2% in cul-
tured tubular epithelium NRK-52E cells [45]. Currently,
LPD has also been shown highly efficient in gene transfer
in vivo upon intracranial injection or systemic adminis-
tration [27, 33]. In this study, we investigated the distri-
bution and duration of FITC-labeled ODN delivered by
LPD via the renal artery. Fluorescence was mainly de-
tected in glomeruli 2 hours after transfection, whereas
accumulated in tubules 12 hours later. Treated with naked
FITC-ODN, even 10 times higher, there was no detection
of fluorescence in either glomeruli or tubules. These data
suggested that the use of LPD method together with renal
artery infusion was an effective means to transfect tubu-
lar epithelium with ODN in vivo. Therefore, it enables us
to use NF-jB decoy strategy in the treatment of ischemic
ARF.
NF-jB is a redox-sensitive transcription factor that
could be activated by many stimuli, including ischemia
and reactive oxygen intermediates, produced in the fol-
lowed reperfusion [14]. In this study, we demonstrated
that a significant increase of NF-jB DNA binding ac-
tivities occurred after 60 minutes ischemia and 24 hours
reperfusion in rat kidney, which confirmed many of pre-
vious investigations [46]. However, our proposal was
not to retest this hypothesis. Indeed, we sought to de-
velop a novel means to interfere with ischemic ARF. We
found that blocking NF-jB activation directly by NF-jB
decoy ODN ameliorated renal ischemic injury both in
functional and histologic criteria. Biochemistry analysis
exhibited that serum creatinine levels decreased by 70%.
Histologically, we observed that the leukocyte infiltration
and tubular damages in the outer medullary stripe in I/R
kidney, where it is most susceptible to hypoperfusion and
hypoxia [46], were markedly reduced after NF-jB decoy
ODN treatment.
Furthermore, results of immunohistochemical stain
in this study showed that a massive of ED-1–positive
M/M were present in ischemic ARF kidneys. It has
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been amused that infiltrated neutrophils indeed can re-
lease damaging agents such as highly reactive enzymes,
oxygen radicals,and nitric oxide following I/R, but the
new evidence demonstrates that M/M is predominating
[7, 46]. M/M remain localized predominantly in the zone
of most severe injury as long as the process of restoring
renal tubular morphology and function lasts.
Local expression of chemokines are thought to be re-
sponsible for the leukocytes migration, accumulation and
activation in the site of injury, among which MCP-1 has
a potent capacity to recruit M/M to infiltration in var-
ious organs [47]. The expression of MCP-1 was elevated
in patients with acute renal transplant rejection, renal
allografts with chronic rejection, and severe warm I/R
rat model [48–50]. In line with those findings, the results
from our present study demonstrated that MCP-1 expres-
sion was markedly increased in the rat kidney upon I/R.
Consequently, we found that MCP-1 localized to the
interstitium and around tubules was keeping with the
accumulation of ED-1–positive cells, which further sup-
ported the hypothesis of MCP-1 as a potentially me-
diator of M/M infiltration. The expression of MCP-1
is mainly controlled at the transcription level by many
factors, among which NF-jB is the most important one
[7, 51]. Sung et al [7] demonstrated that activation of
NF-jB is necessary for I/R-induced MCP-1 expression.
Our data confirmed that expression of MCP-1 increased
concomitantly to the activation of NF-jB in I/R rat kid-
ney, and decreased after the inhibition of NF-jB activi-
ties by NF-jB decoy ODN treatment. Furthermore, we
also observed that pretreatment with NF-jB decoy ODN
not only blocked NF-jB activation and the expression of
MCP-1, but also reduced the infiltration of ED-1–positive
cell. Therefore, We speculate that the activation of
NF-jB may up-regulate the expression of MCP-1 that
attracts the localization of M/M.
M/M infiltration in I/R injury is accompanied by sig-
nificant up-regulation of adhesion molecules [52]. I/R
injury involves activated leukocytes with an enhanced
adhesiveness to endothelium by up-regulates adhesion
protein expression on endothelial and leukocytes, pre-
venting the interaction between them may indeed keep
leukocytes from proceeding to endothelial diapedesis
[53]. Because ICAM-1, a immunoglobulin superfamily
adhesion molecule, appears to involved in the patho-
genesis of ischemic ARF, the renoprotective potential
of directly or indirectly targeting ICAM-1, such as anti-
ICAM-1antibodies, ICAM-1 knockout mice, antisense
ODN for ICAM-1, had been documented in many in-
vestigations [12, 44]. In this present study, we confirmed
that the expression of ICAM-1 mRNA was markedly el-
evated in I/R kidney, which is inhibited by NF-jB de-
coy ODN. Considering to the concomitant variation of
NF-jB activities and infiltration of ED-1–positive cells,
we believed that the expression of ICAM-1 is regulated
by NF-jB, and associates with M/M infiltration. As to
the detailed mechanisms among them were beyond the
scope of this investigation.
The infiltration of M/M and injured tubules are two
hallmarks in I/R kidney [54]. Nevertheless, the initiation
of I/R injury is mostly due to tissue damage, vascular en-
dothelial dysfunction, and impaired vasorelaxation, for
example [11, 55]. ET-1 is the most potent vasoconstrictor
in the renal circulatory bed [56, 57]. By restricting blood
flow in the peritubular capillary network, ET-1 would
cause hypoxia to the adjacent cells lining the tubules in
I/R kidney. Prolonged hypoxia from ongoing vasocon-
striction in this bed could, in turn, lead to cell death and
to the typical tubular epithelial sloughing seen in acute
tubule necrosis [9]. Because the expression of ET-1 is reg-
ulated by NF-jB, the inhibition of the activation of NF-jB
would result in the down-regulation of ET-1 [14]. Ther-
apeutic strategies for inhibition of ET system should be
targeted to prevent ARF. In this study, we observed that
the expression of ET-1 mRNA was markedly increased
in the I/R processes, which coincided to the activation of
NF-jB. Pretreatment of NF-jB decoy ODN could reduce
the ET-1 mRNA level, comparing to the sham-operated
animals. This result implicated that the ET-1 generated in
the kidney was regulated by NF-jB, and involved in the
progression and pathogenesis of ischemic ARF.
Vascular endothelial dysfunction and impaired vasore-
laxation are followed by tubular mechanisms that include
not only the induction of iNOS and increased production
of reactive oxygen intermediates in the renal epithelial
cells, but also generation of peroxynitrite by the infil-
trating M/M, eventually leading to the destruction of
tubular epithelial cells [11, 55, 58]. Furthermore, negative
regulator of iNOS may therefore attenuate nitric oxide–
mediated tubular cytotoxicity [59]. Experiments in iNOS
gene knockout mice [60] as well as antisense ODNs tar-
geting iNOS treatment demonstrated that iNOS block-
ade prevent renal I/R injury [61]. It is well known that
iNOS genes expression is considered as regulated by
NF-jB, and the inhibition of NF-jB activation results
in the down-regulating iNOS expression. In view of the
evidence provided by previous studies concerning the
role of iNOS playing in the pathogenesis of ischemic
ARF [10, 62], the present results seemed to be in agree-
ment with them. In this study, we demonstrated that
iNOS mRNA expression increased dramatically and the
protein massively distributed along injured tubules and
in interstitium, which corresponded with the localiza-
tion of ED-1–positive cells, in I/R kidneys. Furthermore,
our data showed this elevation and distribution of iNOS
were suppressed after NF-jB decoy ODN treatment.
From these results, we speculated that the production of
iNOS might be derived from injured tubules and M/M,
was regulated by NF-jB, and contributed to tubular
injury.
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CONCLUSION
We demonstrated (1) lipid-protamine mediated ODN
transfection appeared high efficacy in renal tubules in
vivo; (2) the activation of NF-jB played a central role in
the pathogenesis of ischemic ARF by regulating the ex-
pression of MCP-1, ICAM-1, iNOS and ET-1, which re-
lated to the infiltration of M/M and tubular damage; and
(3) NF-jB decoy treatment ameliorated ischemic ARF
by blocking NF-jB activation, furthering inhibition the
expression of MCP-1, ICAM-1, iNOS, and ET-1. Thus,
lipid-protamine–mediated NF-jB decoy ODN strategy
provided a novel therapeutic way for ischemic ARF
treatment.
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